Home/Filings/4/0001437749-24-019348
4//SEC Filing

Sieger Markus 4

Accession 0001437749-24-019348

CIK 0000922247other

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 5:10 PM ET

Size

7.0 KB

Accession

0001437749-24-019348

Insider Transaction Report

Form 4
Period: 2024-06-03
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-06-03+15,56215,562 total
    Exercise: $1.28Exp: 2034-06-03Common Stock (15,562 underlying)
  • Award

    Common Stock

    2024-06-03+18,067328,746 total
Footnotes (2)
  • [F1]Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the issuer's non-employee director compensation policy. Grant reflects director compensation for the first quarter of 2024. The number of shares received in lieu of cash was calculated based on the closing price of $1.28 per share of common stock on June 3, 2024.
  • [F2]The option vests over a one year period in equal quarterly installments.

Issuer

Cyclo Therapeutics, Inc.

CIK 0000922247

Entity typeother

Related Parties

1
  • filerCIK 0001337143

Filing Metadata

Form type
4
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 5:10 PM ET
Size
7.0 KB